WP4 OTCA05 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is now available.
We are pleased to announce that the CA of JA3 WP4 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is available. The purpose of the assessment is to examine the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in adult patients with treatment-resistant major depression. The analysis included CE-marked rTMS devices. Final version […]
WP4 OTCA01 Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk is now available.
We are pleased to announce that the 1st Collaborative Assessment of WP4 AC-B on “Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk” is ready now available. Sudden cardiac arrest (SCA) is the most common cause of death in patients with coronary artery disease. Mostly, ventricular tachycardia […]
Launch of a public consultation during the EC-EUnetHTA Forum
The EC-EUnetHTA Forum “European cooperation on HTA: what’s next?” co-organised by the European Commission and the EUnetHTA Joint Action 3 was the first meeting between all 79 EUnetHTA partner organisations and the broader HTA stakeholder community. The event was well attended and the lively discussions were structured around three panels: • Panel 1: EU cooperation […]
Launch of a public consultation during the EC-EUnetHTA Forum
The EC-EUnetHTA Forum “European cooperation on HTA: what’s next?” co-organised by the European Commission and the EUnetHTA Joint Action 3 was the first meeting between all 79 EUnetHTA partner organisations and the broader HTA stakeholder community. The event was well attended and the lively discussions were structured around three panels: Panel 1: EU cooperation on […]
Invitation to participate in the EC-EUnetHTA Forum
The Forum entitled “European Cooperation on HTA: What’s next?” is jointly organized by the European Commission and EUnetHTA and EC on the 21st of October 2016 in Brussels (The Square conference center). The event will be an opportunity for the European Commission to provide further information on the upcoming public consultation on the future of […]
EUnetHTA-EFPIA Technical meeting
On the 7th June 2016, a technical meeting was held in Paris, hosted by Haute Autorité de Santé (HAS, EUnetHTA Work Package 5 lead). The participants of this meeting not only included all EUnetHTA Joint Action 3 WP leads, but also representatives from industry (pharmaceutical), European Federation of Pharmaceutical Industries and Associations (EFPIA), European Medicines […]
Signing of the Grant Agreement for Joint Action 3 started
The Dutch National Health Care Institute and the European Commission signed the Grant Agreement on the 25th of August 2016. Within 30 days all organisations need to sign in order to join the creation of sustainable HTA network. Then Joint Action 3 will start officially. The Dutch National Health Care Institute and the European Commission […]
National implementation and uptake in Joint Action 3
Work Package 7 supports the production of a sustainable model by making the implementation mechanism facilitate uptake and implementation in national, regional and local settings. Work Package 7 supports the production of a sustainable model by making the implementation mechanism facilitate uptake and implementation in national, regional and local settings. The objectives: 1. provide technical […]
Work Package 4: Joint productions
This work package focuses on the production of joint health technology assessments. The joint assessments should be fit for purpose, of high quality, of timely availability, and cover the whole range of health technologies. The objectives of Work Package 4 are: 1. To produce joint health technology assessments. The joint assessments should be fit for […]
Work Packages overview: horizontal work packages
EUnetHTA JA3 is organized into three horizontal work packages (WP1-3), and four core work packages (WP4-7). The horizontal work packages will coordinate the Joint Assessment, disseminate its results and evaluate the main objective of this Joint Assessment. The core work packages will deliver products needed for a sustainable HTA network like quality joint assessments, evidence […]
